1 results match your criteria: "Novartis Institute for Biomedical Research Basel[Affiliation]"

Screening for Inhibitors of Kinase Autophosphorylation.

Methods Mol Biol

December 2017

Center for Proteomic Chemistry, Novartis Institute for Biomedical Research Basel, Novartis Pharma AG, Postfach, CH-4002, Basel, Switzerland.

Autophosphorylation of kinases influences their conformational state and can also regulate enzymatic activity. Recently, this has become an area of interest for drug discovery. Using Alk2 as an example, we present two protocols - one based on phosphate-binding Alphascreen beads, the other on coupled luminescence measurements of ADP formation - that can be used to screen for inhibitors of autophosphorylation.

View Article and Find Full Text PDF